HORG Group

The Hematology Oncology Research Group (HORG) is a specialized clinical research organization and collaborative network focused on advancing treatments for blood cancers and solid tumors. Based in Singapore, the group facilitates multi-center clinical trials and provides comprehensive research services to pharmaceutical and biotechnology partners across the Asia-Pacific region. HORG integrates clinical expertise with robust data management and regulatory support to accelerate the development of novel oncology therapeutics. By bridging the gap between academic research and industry needs, the organization plays a critical role in bringing innovative hematology and oncology treatments to patients.